Healthcare Services

Customized Genetic Testing Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Customized Genetic Testing Market From 2026 To 2030?

The customized genetic testing market has experienced significant expansion in recent years. This market is projected to grow from $14.13 billion in 2025 to $16.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.0%. The historical growth can be linked to factors such as heightened awareness of hereditary diseases, the decreasing cost of genetic sequencing, the expansion of clinical genetic counseling services, a rising adoption of predictive testing, and the increasing use of molecular diagnostics.

The customized genetic testing market is anticipated to experience substantial growth over the coming years, with its size projected to reach $29.5 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.8%. This expansion in the forecast period is primarily fueled by the escalating demand for personalized medicine, the increasing integration of genomics into routine healthcare, the broader implementation of preventive healthcare strategies, a growing adoption of precision oncology, and increased investments in genomic data platforms. Significant trends during this period are expected to include the rising adoption of personalized genetic panels, the expanded application of NGS-based customized testing, the wider use of pharmacogenomic applications, an increasing need for targeted risk assessment, and enhanced integration of clinical decision support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28187&type=smp

What Major Drivers Are Influencing Demand In The Customized Genetic Testing Market?

The future expansion of the customized genetic testing market is anticipated, driven by the rising acceptance of personalized medicine. This medical strategy involves customizing treatments, preventative measures, and health choices to suit each patient’s unique attributes. The growing uptake of personalized medicine stems from advancements in genomics, proteomics, and biomarker discovery, facilitating treatments aligned with individual genetic profiles and boosting the need for specific therapies, better diagnostics, and precise healthcare. Within this transformation, customized genetic testing is crucial, offering comprehensive genetic information that allows for accurate disease risk evaluations, focused treatments, and preventative health measures. As an example, the US-based nonprofit, Personalized Medicine Coalition, stated in February 2024 that the United States Food and Drug Administration (FDA) sanctioned 16 novel personalized therapies for individuals with rare diseases in 2023, a significant increase from only 6 approvals observed in 2022. Consequently, the expanding implementation of personalized medicine is fueling the growth of the customized genetic testing market.

Which Segments Are Included In The Analysis Of The Customized Genetic Testing Market?

The customized genetic testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing

2) By Sample Type: Saliva, Blood, Buccal Swab

3) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Single-Cell Sequencing

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders

5) By End-User: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing

Subsegments:

1) By Predictive Testing: Cancer Susceptibility Testing, Neurodegenerative Disorder Testing, Cardiovascular Disease Risk Testing, Metabolic Disorder Risk Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Sickle Cell Anemia Carrier Testing, Tay–Sachs Disease Carrier Testing, Thalassemia Carrier Testing

3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Panels, Chorionic Villus Sampling (CVS), Amniocentesis-Based Genetic Testing

4) By Diagnostic Testing: Rare Disease Diagnosis, Oncology Genetic Testing, Neurological Disorder Diagnosis, Infectious Disease-Associated Genetic Testing

5) By Pharmacogenomic Testing: Drug Metabolism Testing, Oncology Pharmacogenomics, Cardiovascular Drug Response Testing, Psychiatric Drug Response Testing

What Major Market Trends Are Driving Changes In The Customized Genetic Testing Market?

Major corporations active in the customized genetic testing market are progressively emphasizing direct-to-consumer solutions, particularly at-home DNA testing paired with customized health plans derived from individual genetic profiles. At-home DNA testing is a form of genetic assessment that individuals can conduct outside a clinical environment, usually by acquiring a kit online or from a pharmacy, collecting a saliva or cheek swab sample at their residence, and subsequently mailing it to a laboratory for analysis. For instance, in May 2025, Hydreight Technologies Inc., a Canada-based digital health technology company, launched a personalized genetic testing and wellness solution on its VSDHOne Platform. This service provides patients with convenient access to at-home DNA testing kits and offers tailored health plans covering nutrition, fitness, supplementation, and medication compatibility. Additionally, the platform ensures ongoing care through integrated telehealth services and in-person consultations delivered by licensed healthcare professionals.

Which Key Industry Participants Are Active In The Customized Genetic Testing Market?

Major companies operating in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics

Read the full customized genetic testing market report here:

https://www.thebusinessresearchcompany.com/report/customized-genetic-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Customized Genetic Testing Market?

North America was the largest region in the customized genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the customized genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Customized Genetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28187&type=smp

Browse Through More Reports Similar to the Global Customized Genetic Testing Market 2026, By The Business Research Company

Addictions Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Targeted Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795